Medicine and Dentistry
Immunoglobulin A Nephropathy
100%
Renal Replacement Therapy
94%
Peritoneal Dialysis
79%
Kidney Transplantation
68%
Biopsy Technique
48%
Peritonitis
45%
Kidney Graft
42%
B Cell
40%
Kidney Graft Rejection
40%
Morphological Trait
40%
Dialysis Catheter
23%
Prevalence
23%
Disease Course
22%
Hyperuricemia
22%
Immunoglobulin A
22%
End Stage Renal Disease
22%
Glomerular Filtration Rate
22%
Hemodialysis
21%
Diastolic Blood Pressure
21%
Chronic Kidney Disease
20%
Anemia
20%
Dysbiosis
20%
Granulomatosis with Polyangiitis
20%
Central Retinal Artery Occlusion
20%
Leucine
20%
Alpha2 Glycoprotein
20%
Gallbladder Perforation
20%
Living Donors
17%
Antibody Mediated Rejection
17%
Diabetes Mellitus
16%
Proportional Hazards Model
13%
Survival Rate
13%
Odds Ratio
13%
Pulse Rate
12%
Morphology
11%
COVID-19
11%
COVID-19 Vaccination
11%
Comorbidity
11%
Acute Graft Rejection
10%
Case Presentation
10%
Hope
10%
Radioisotope Renography
10%
Dialysis Fluid
10%
Cholecystectomy
10%
Proteinuria
9%
Nephrology
9%
Immunosuppressive Treatment
9%
Renal Failure
8%
Allograft
8%
Prednisolone
8%
Immunology and Microbiology
IgA Nephropathy
80%
B Cell
60%
Kidney Graft Rejection
40%
Antibody Mediated Rejection
40%
Immunoglobulin A
33%
Allograft
27%
Acute Graft Rejection
25%
Immunosuppression
22%
Glomerulus Filtration
22%
Kidney Transplantation
21%
Staphylococcus Aureus
20%
Peritoneal Dialysis
20%
Creatinine Blood Level
20%
Complement Component 3
20%
Complement Component 4
20%
Complement
20%
Cell Population
20%
Bacteriophage
20%
Biofilm
20%
Morphological Trait
20%
Rituximab
18%
Immunoglobulin
14%
Blood Plasma
14%
Anti-Thymocyte Globulin
10%
Transplant Rejection
10%
Pulse Rate
10%
Peritonitis
5%
B Cell Activation
5%
CD43
5%
Antimicrobial Resistance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Peritonitis
45%
Leucine
40%
Alpha2 Glycoprotein
40%
Anemia
31%
Tubular Dysfunction
26%
Kidney Injury
21%
Chronic Kidney Failure
20%
Bacteriophage
20%
Staphylococcus Aureus
20%
Hyperuricemia
20%
Biological Marker
18%
Uric Acid
17%
Proteinuria
16%
Cystatin C
13%
End Stage Renal Disease
12%
Diabetes Mellitus
9%
Heart Left Ventricle Hypertrophy
8%
Cardiovascular Risk
8%
Inflammation
8%
Enzyme-Linked Immunosorbent Assay
8%
Deterioration
8%
Lipocalin
6%
Gelatinase
6%
Replacement Therapy
6%
Creatinine
6%
Ureaplasma
6%
Antimicrobial Resistance
5%
Diuretics
5%
Albumin
5%
